Clinical Trial Update: Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of temozolomide and VNP40101M in patients with relapsed or refractory leukemia. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Temozolomide (Temozolomide)
• VNP40101M

Snippet

Sponsor: Vion Pharmaceuticals | Conditions: Leukemia | Phase 1 | Status: COMPLETED